Aberrant cerebral network topology and mild cognitive impairment in early Parkinson's disease

Joana B Pereira1, Dag Aarsland2,3, Cedric E Ginestet4

  • 1Department of Neurobiology, Care Sciences and Society, Division of Clinical Geriatrics, Karolinska Institutet, Stockholm, Sweden.

Insights

Mild cognitive impairment in Parkinson's disease (PD) is linked to disrupted brain networks. Early detection of these network changes may predict future cognitive decline in PD patients.

Area of Science:

  • Neuroscience
  • Neurology
  • Medical Imaging

Background:

  • Parkinson's disease (PD) is a neurodegenerative disorder often accompanied by cognitive impairment.
  • Early identification of cognitive decline in PD is crucial for management and prognosis.
  • Large-scale brain network disruptions may underlie cognitive changes in early PD.

Purpose of the Study:

  • To investigate the association between mild cognitive impairment (MCI) and structural brain network alterations in newly diagnosed, drug-naïve Parkinson's disease (PD) patients.
  • To analyze graph theoretical properties of brain networks in PD patients with and without MCI.

Main Methods:

  • Utilized 3T MRI data from 123 PD patients and 56 controls from the Parkinson's Progression Markers Initiative (PPMI).
  • Applied graph theoretical analyses to structural networks derived from cortical thickness and subcortical volume data.
  • Classified PD patients into Parkinson's disease with mild cognitive impairment (PD-MCI) and cognitively normal (PD-CN) groups.

Main Results:

  • PD-MCI patients exhibited reduced average correlation strength between cortical and subcortical regions compared to controls.
  • PD-MCI patients showed increased characteristic path length, reduced global efficiency, and lower regional efficiency in frontal and parietal areas.
  • Both PD-MCI and PD-CN groups displayed reorganization of highly connected brain regions.

Conclusions:

  • Early cognitive decline in PD is associated with disrupted large-scale brain network coordination.
  • Reduced network efficiency in parallel information processing is observed in PD-MCI.
  • Aberrant brain network topology likely contributes to cognitive impairment in early Parkinson's disease.

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.4K
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
45.1K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K